Report Detail

Other Global Drugs for Schistosomiasis Market Research Report 2012-2024

  • RnM3590725
  • |
  • 12 July, 2019
  • |
  • Global
  • |
  • 86 Pages
  • |
  • HeyReport
  • |
  • Other

Summary
Schistosomiasis, also known as snail fever and bilharzia, is a disease caused by parasitic flatworms called schistosomes. The urinary tract or the intestines may be infected. Signs and symptoms may include abdominal pain, diarrhea, bloody stool, or blood in the urine. Those who have been infected a long time may experience liver damage, kidney failure, infertility, or bladder cancer. In children, it may cause poor growth and learning difficulty.
The global Drugs for Schistosomiasis market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
Praziquantel
Oxamniquine
Others
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Merck
Shin Poong
Bayer
EIPICO
Chandra Bhagat Pharma
Taj Pharmaceuticals
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
S. haematobium
S. mansoni
S. japonicum
S. mekongi
S. intercalatum
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa


Table of Contents

    1 Market Overview

    • 1.1 Objectives of Research
      • 1.1.1 Definition
      • 1.1.2 Specifications
    • 1.2 Market Segment
      • 1.2.1 by Type
        • 1.2.1.1 Praziquantel
        • 1.2.1.2 Oxamniquine
        • 1.2.1.3 Others
      • 1.2.2 by Application
        • 1.2.2.1 S. haematobium
        • 1.2.2.2 S. mansoni
        • 1.2.2.3 S. japonicum
        • 1.2.2.4 S. mekongi
        • 1.2.2.5 S. intercalatum
      • 1.2.3 by Regions

    2 Industry Chain

    • 2.1 Industry Chain Structure
    • 2.2 Upstream
    • 2.3 Market
      • 2.3.1 SWOT
      • 2.3.2 Dynamics

    3 Environmental Analysis

    • 3.1 Policy
    • 3.2 Economic
    • 3.3 Technology
    • 3.4 Market Entry

    4 Market Segmentation by Type

    • 4.1 Market Size
      • 4.1.1 Praziquantel Market, 2013-2018
      • 4.1.2 Oxamniquine Market, 2013-2018
      • 4.1.3 Others Market, 2013-2018
    • 4.2 Market Forecast
      • 4.2.1 Praziquantel Market Forecast, 2019-2024
      • 4.2.2 Oxamniquine Market Forecast, 2019-2024
      • 4.2.3 Others Market Forecast, 2019-2024

    5 Market Segmentation by Application

    • 5.1 Market Size
      • 5.1.1 S. haematobium Market, 2013-2018
      • 5.1.2 S. mansoni Market, 2013-2018
      • 5.1.3 S. japonicum Market, 2013-2018
      • 5.1.4 S. mekongi Market, 2013-2018
      • 5.1.5 S. intercalatum Market, 2013-2018
    • 5.2 Market Forecast
      • 5.2.1 S. haematobium Market Forecast, 2019-2024
      • 5.2.2 S. mansoni Market Forecast, 2019-2024
      • 5.2.3 S. japonicum Market Forecast, 2019-2024
      • 5.2.4 S. mekongi Market Forecast, 2019-2024
      • 5.2.5 S. intercalatum Market Forecast, 2019-2024

    6 Market Segmentation by Region

    • 6.1 Market Size
      • 6.1.1 Asia-Pacific
        • 6.1.1.1 Asia-Pacific Market, 2012-2018
        • 6.1.1.2 Asia-Pacific Market by Type
        • 6.1.1.3 Asia-Pacific Market by Application
      • 6.1.2 North America
        • 6.1.2.1 North America Market, 2012-2018
        • 6.1.2.2 North America Market by Type
        • 6.1.2.3 North America Market by Application
      • 6.1.3 Europe
        • 6.1.3.1 Europe Market, 2012-2018
        • 6.1.3.2 Europe Market by Type
        • 6.1.3.3 Europe Market by Application
      • 6.1.4 South America
        • 6.1.4.1 South America Market, 2012-2018
        • 6.1.4.2 South America Market by Type
        • 6.1.4.3 South America Market by Application
      • 6.1.5 Middle East & Africa
        • 6.1.5.1 Middle East & Africa Market, 2012-2018
        • 6.1.5.2 Middle East & Africa Market by Type
        • 6.1.5.3 Middle East & Africa Market by Application
    • 6.2 Market Forecast
      • 6.2.1 Asia-Pacific Market Forecast, 2019-2024
      • 6.2.2 North America Market Forecast, 2019-2024
      • 6.2.3 Europe Market Forecast, 2019-2024
      • 6.2.4 South America Market Forecast, 2019-2024
      • 6.2.5 Middle East & Africa Market Forecast, 2019-2024

    7 Market Competitive

    • 7.1 Global Market by Vendors
    • 7.2 Market Concentration
    • 7.3 Price & Factors
    • 7.4 Marketing Channel

    8 Major Vendors

    • 8.1 Merck
    • 8.2 Shin Poong
    • 8.3 Bayer
    • 8.4 EIPICO
    • 8.5 Chandra Bhagat Pharma
    • 8.6 Taj Pharmaceuticals

    9 Conclusion

    Summary:
    Get latest Market Research Reports on Drugs for Schistosomiasis . Industry analysis & Market Report on Drugs for Schistosomiasis is a syndicated market report, published as Global Drugs for Schistosomiasis Market Research Report 2012-2024. It is complete Research Study and Industry Analysis of Drugs for Schistosomiasis market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $2,060.00
    $2,470.00
    $3,210.00
    1,619.16
    1,941.42
    2,523.06
    1,903.44
    2,282.28
    2,966.04
    322,554.80
    386,752.60
    502,621.80
    171,577.40
    205,726.30
    267,360.90
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report